EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

LncRNA NEAT1 restrains the malignant biological characteristics of acute myeloid leukemia via regulating CTCF/CXCR2 axis

Yanquan Liu, Zuotao Li, Jingdong Zhang, Jianzhen Shen, Hehui Zhang, Yue Yin, Lei Sun, Huanwen Tang

Clinical and Experimental Medicine · 2025

DOI: 10.1007/s10238-025-01975-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2025. Verfasst von Yanquan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Health Commission Key Laboratory of Leukemia, Jiangxi Medical College, The Affiliated Ganzhou Hospital (Ganzhou People's Hospital), Nanchang …. Hauptthemen laut MEDLINE: RNA, Long Noncoding, CCCTC-Binding Factor, Leukemia, Myeloid, Acute, Receptors, Interleukin-8B. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Opening Fund of Jiangxi Health Commission Key Laboratory of Leukemia, Science and Technology Plan Fund of Jiangxi Provincial Administration of Traditional Chinese Medicine, Science and Technology Research Project of Jiangxi Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is notorious in the field of hematology for its poor efficacy, frustrating prognosis, and it is prone to refractory or relapsed conditions. Previous studies in our team have shown that some Long noncoding RNAs (lncRNAs) and chemokine receptors play key regulatory roles in AML. The findings of this study demonstrated that the expression of NEAT1 was atypically low in both clinical AML specimens and AML cell lines. Overexpression of NEAT1 was capable of attenuating the malignant biological characteristics of AML cells, including inhibiting the malignant proliferation and colony formation of leukemia cells, and facilitating cell apoptosis. We identified and clarified the binding capacity or interaction between NEAT1 and CTCF as well as CTCF and CXCR by employing experimental techniques such as RNA pull down, RNA immunoprecipitation (RIP), and chromatin immunoprecipitation (ChIP). Additionally, our previous studies have affirmed that CXCR2 plays an indispensable role in the pathogenesis of leukemia, and what is astonishing in this study is that CTCF might have a targeted regulatory relationship with CXCR2. CTCF was identified as a NEAT1 target and transcriptionally activated the expression of CXCR2 in AML cells. Correspondingly, we also discovered that NEAT1 could influence the malignant biological behavior of AML cells by down-regulating MYC to activate the CTCF/CXCR2 signaling axis. In salvage experiments, targeted inhibition of CTCF and CXCR2 knockout (CRISPR CAS9) reversed the promoting effect of NEAT1 inactivation on AML progression and suppressed the malignant phenotype. More importantly, the in vivo experiments in this study corroborate the reliability of the conclusions drawn from in vitro cell experiments and further demonstrate that LncRNA NEAT1 inhibits the malignant biological characteristics of acute myeloid leukemia by mediating the CTCF/CXCR2 regulatory axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingCCCTC-Binding FactorLeukemia, Myeloid, AcuteReceptors, Interleukin-8BHumansAnimalsCell Line, TumorCell ProliferationFemaleMaleApoptosisMiceGene Expression Regulation, Leukemic

Stichwörter der Autor:innen

Acute myeloid leukemiaCTCF/CXCR2 axisCell therapyGene therapyLeukemic cellLncRNA NEAT1Molecular mechanismTargeted therapy

Substanzen

RNA, Long NoncodingCCCTC-Binding FactorCTCF protein, humanReceptors, Interleukin-8BNEAT1 long non-coding RNA, human

Autor:innen und Institutionen

  • Jiangxi Health Commission Key Laboratory of Leukemia, Jiangxi Medical College, The Affiliated Ganzhou Hospital (Ganzhou People's Hospital), Nanchang University, Ganzhou, 341000, China. doctorliuyanquan@gdmu.edu.cn.
  • The First Affiliated Hospital (the First Clinical Medical College) of Gannan Medical University, Ganzhou, 341000, China.
  • Jiangxi Health Commission Key Laboratory of Leukemia, Jiangxi Medical College, The Affiliated Ganzhou Hospital (Ganzhou People's Hospital), Nanchang University, Ganzhou, 341000, China.
  • Fujian Institute of Hematology, National Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
  • Department of Hematology, Dongguan Key Laboratory of Environmental Medicine, School of Public Health, The First Dongguan Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Dongguan, 52380…

Förderung

  • Opening Fund of Jiangxi Health Commission Key Laboratory of Leukemia
  • Science and Technology Plan Fund of Jiangxi Provincial Administration of Traditional Chinese Medicine
  • Science and Technology Research Project of Jiangxi Provincial Department of Education

Zitieren

APA

Liu, Y., Li, Z., Zhang, J., Shen, J., Zhang, H., Yin, Y., Sun, L., & Tang, H. (2025). LncRNA NEAT1 restrains the malignant biological characteristics of acute myeloid leukemia via regulating CTCF/CXCR2 axis. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-025-01975-7

Vancouver

Liu Y, Li Z, Zhang J, Shen J, Zhang H, Yin Y, et al. LncRNA NEAT1 restrains the malignant biological characteristics of acute myeloid leukemia via regulating CTCF/CXCR2 axis. Clinical and Experimental Medicine. 2025. doi:10.1007/s10238-025-01975-7

BibTeX
@article{Liu2025,
  author = {Liu, Yanquan and Li, Zuotao and Zhang, Jingdong and Shen, Jianzhen and Zhang, Hehui and Yin, Yue and Sun, Lei and Tang, Huanwen},
  title = {LncRNA NEAT1 restrains the malignant biological characteristics of acute myeloid leukemia via regulating CTCF/CXCR2 axis},
  journal = {Clinical and Experimental Medicine},
  year = {2025},
  doi = {10.1007/s10238-025-01975-7}
}
Kostenlos starten →